Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CVS HEALTH CORPORATION

(CVS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

CVS Health : responds to latest update on COVID-19 vaccinations and testing

09/09/2021 | 06:02pm EDT

Vaccinating more Americans is clearly the most effective way to prevail over the pandemic. We've administered more than 30 million vaccines, with a particular focus on those more susceptible to COVID-19, and are prepared to play a leading role in providing booster shots.

We've been ahead of the curve when it comes to vaccinations for our employees, announcing a requirement in August that impacts many of our 300,000 colleagues. We'll review new requirements proposed by the administration and act accordingly.

COVID-19 testing continues to be a critical focus for us as well, with more than 30 million tests administered to date. We currently offer free testing at nearly 5,000 locations across the country, and recently expanded to more high-risk, underserved communities. We also offer four home testing products as a convenient alternative.

Disclaimer

CVS Health Corporation published this content on 09 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 September 2021 22:01:03 UTC.


ę Publicnow 2021
All news about CVS HEALTH CORPORATION
10/12VC DAILY : Is It All or Nothing for Founders?
DJ
10/06AMAZON COM : Bank of America raises U.S. minimum hourly wage to $21
RE
10/05CVS HEALTH : Keeps Quarterly Dividend Unchanged at $0.50 a Share, Payable Nov. 1 to Shareh..
MT
10/05CVS HEALTH : Announces Quarterly Dividend
PR
10/05CVS Health Corporation Announces Quarterly Dividend, Payable on November 1, 2021
CI
10/04WALGREENS BOOTS ALLIANCE : Pharmacy chains failed to prevent opioid misuse, U.S. jury hear..
RE
10/01CVS HEALTH : To Hold Third Quarter 2021 Earnings Conference Call
PR
10/01CVS HEALTH : Aetna 2022 Medicare plans feature more benefits, lower member costs and great..
PR
10/01Pharmacy chains face first trial in U.S. opioid litigation, judge urges settlement
RE
09/29CVS HEALTH : to invest $25 million in affordable housing in Louisiana
PU
More news
Analyst Recommendations on CVS HEALTH CORPORATION
More recommendations
Financials (USD)
Sales 2021 284 B - -
Net income 2021 8 455 M - -
Net Debt 2021 49 027 M - -
P/E ratio 2021 13,4x
Yield 2021 2,32%
Capitalization 113 B 113 B -
EV / Sales 2021 0,57x
EV / Sales 2022 0,53x
Nbr of Employees 256 500
Free-Float 75,6%
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | CVS | US1266501006 | MarketScreener
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Last Close Price 85,84 $
Average target price 96,89 $
Spread / Average Target 12,9%
EPS Revisions
Managers and Directors
Karen S. Lynch President, Chief Executive Officer & Director
Shawn M. Guertin Chief Financial Officer & Executive Vice President
David Wyatt Dorman Chairman
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
Sector and Competitors